M&A Science

Samuel Wilson, Chief Executive Officer at 8x8 (NASDAQ: EGHT)

In the grand scheme of things, every M&A must make financial sense. Whether it's cutting cost, increasing revenue, or achieving operational efficiencies, it all boils down to the numbers. After all, every company's main goal is to grow and increase profit for its shareholders. It is why the Chief Financial Officers play an integral role in M&A.

In this episode of the M&A Science Podcast, we will explore M&A from a CFO's perspective, featuring Samuel Wilson, Chief Executive Officer at 8x8.

____________________________________________________________________________

This episode is sponsored by the DealRoom and FirmRoom.

Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net

FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com.

00:00 Intro

07:55 The Role of CFO

11:39 Risk Management

14:39 Integration aspect

15:54 Alignment on assumptions

18:14 Managing people

19:28 Best integration practices

21:25 Working with the CEO

22:52 Walking away from a deal

27:10 Getting involved in the deal

29:50 Tying the Strategy

33:36 Integration Budgeting

39:43 Working with corporate development

40:54 Advice for first time acquirers

44:04 Craziest thing in M&A

David Barnes, Chief Financial Officer at Trimble Inc. (NASDAQ:TRMB)

Chief Financial Officers (CFOs) play a pivotal role in shaping the destiny of strategic ventures. Beyond their traditional financial responsibilities, these financial architects hold the key to unlocking the full potential of mergers and acquisitions.

In this episode of the M&A Science Podcast, we explore M&A from a CFO's perspective with David Barnes, Chief Financial Officer at Trimble Inc.

____________________________________________________________________________

This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.

To join our growing online community of M&A practitioners, visit mascience.com/academy.

Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at dealroom.net.

FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to firmroom.com.

00:00 Intro

04:29 The Role of CFO

05:14 How the CFO's roles differs from the CEO

06:24 Decision-making process and approvals workflow

09:43 Communicating opportunities

11:15 Prioritization

14:18 Balancing the allocation of budgets

16:42 How equity compensation works

18:14 How aligned investment analysts are when evaluating a company

20:08 Forecasting deals

22:53 Priorities when looking at deals

26:49 Balancing priorities when structuring earnouts

28:31 Understanding a company's culture

31:08 Integration from a CFO's perspective

33:49 How the speed of integration impacts value realization

37:05 Biggest lessons learned as a CFO

39:23 How to pitch deals to the CFO

41:38 Craziest thing in M&A

Joe Metzger, Managing Director at 777 Partners

Navigating a career shift can be a transformative experience, unlocking new opportunities and challenges. For Joe Metzger, Managing Director at 777 Partners, diving into the world of private equity was an exciting path to explore. It's a chance to grow expertise, collaborate with diverse entities, and embrace strategic growth.

In this episode of the M&A Science Podcast, Joe shares his amazing journey shifting from corporate development to private equity.

____________________________________________________________________________

Craving for fresh, actionable M&A insights? Dive into the M&A Science Fall Summit this Nov 8th! Unlock secrets on integration, valuations, talent retention, and more from top M&A minds. It's all the 'how-tos' you need, and it's FREE! Secure your spot at mascience.com.

00:00 Intro

05:02 Transitioning from Corporate Development to Private Equity

08:59 Corporate Development role vs Private Equity role

12:10 Seeking employment opportunities

16:16 The efficient frontier concept

20:06 Are you happier in private equity than in corporate development?

24:17 How to negotiate employment offers

26:48 Other things to negotiate in employment agreements

30:47 How to land a PE role

33:34 Advice to those considering transitioning between Corp Dev and Private Equity

34:52 How to transition to a PE role from a VC and M&A role

36:03 Craziest thing in M&A

Chris Evans, Experienced M&A Leader | former Head of CorpDev Integration at Amazon and Scott Boyd, Deputy Director, Strategy Implementation at Bill & Melinda Gates Foundation | former Head of Integration for AWS. (NASDAQ: AMZN)

Change management is one of the most crucial aspects of M&A. While integration involves multiple facets, from supply chains to customers, change management is solely focused on the employees. This can make or break a deal, as employee retention is one of the main ingredients to achieving synergies in a timely manner.

In this episode of the M&A Science podcast, Chris Evans, former Head of CorpDev Integration at Amazon and Scott Boyd, former Head of Integration for AWS, discusses integration strategies change management person. particularly the nuisances of change management.

____________________________________________________________________________

Craving for fresh, actionable M&A insights? Dive into the M&A Science Fall Summit this Nov 8th! Unlock secrets on integration, valuations, talent retention, and more from top M&A minds. It's all the 'how-tos' you need, and it's FREE! Secure your spot at MAscience.com!

Episode Timestamps

00:00 Intro

02:26 Integration Strategy vs Change Management

06:50 Definition of Change Management

09:55 Dedicated Person for Change Management

14:03 Change Management Planning

16:16 Most Effective Approach to Change Management

19:32 Common Challenges during Change Management

24:25 Practical Tips for Change Management

26:49 Hardest Step in M&A

33:38 Craziest Thing in M&A

Chris Evans, Experienced M&A Leader | former head of CorpDev Integration at Amazon and Scott Boyd, Deputy Director, Strategy Implementation at Bill & Melinda Gates Foundation | former Head of Integration for AWS. (NASDAQ: AMZN)

In the complex world of M&A, the difference between a successful deal and a failed one often hinges on integration. Proper integration, driven by a harmonious fusion of strategy and execution, ensures that the merging entities can effectively combine their strengths and navigate potential pitfalls.

In this two-part episode of the M&A Science Podcast, we dive deep into the heart of integration strategies and underscores the pivotal role of the integration team during the due diligence process, featuring Chris Evans, ex-Head of CorpDev Integration at Amazon and Scott Boyd, former Head of Integration for AWS.

____________________________________________________________________________

Craving for fresh, actionable M&A insights? Dive into the M&A Science Fall Summit this Nov 8th! Unlock secrets on integration, valuations, talent retention, and more from top M&A minds. It's all the 'how-tos' you need, and it's FREE! Secure your spot at mascience.com.

00:00 Intro

06:11 Types of Integration Strategies

09:14 Transformative Integration

11:39 Deals Easy to Integrate

13:24 Most difficult thing to Integrate

15:40 Timeline of integration planning

20:26 Benefits of Integration teams running diligence

25:49 Integration Teams' Diligence Execution

28:46 Structuring the M&A Function

34:39 Consistency vs. agility

40:10 Understanding culture pre LOI

44:34 Working with inexperienced business leaders

46:59 Questions to ask pre-LOI as an Integration leader

Roy Schoenberg, President & Co-CEO at Amwell - American Well Corporation (NYSE:AMWL)

The healthcare industry is a complex and rigid space where change is often rejected. Any evolution in this sector not only signifies business decisions but also influences the overall quality and accessibility of patient care.

In this episode of the M&A Science Podcast, Roy Schoenberg, President & Co-CEO at Amwell, delves into the intricacies of navigating M&A in the healthcare industry.

____________________________________________________________________________

This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.

To join our growing online community of M&A practitioners, visit www.mascience.com/academy.

Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net.

FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com.

Episode Timestamps

00:00 Intro

04:26 Evolving from a medical background to M&A

07:27 What makes the healthcare space distinct

09:36 What drove Amwell to do acquisitions

13:03 Shaping the acquisition strategy

16:59 Amwell's first acquisition

22:29 Integrating the new company

24:50 Retaining key people

28:33 First acquisition lessons learned

31:03 Dealing with transaction surprises

34:03 Approaching deals as one of the main principal

38:01 Deal sourcing

39:49 Managing relationships with the counterparty

41:30 Communication during diligence

43:14 Craziest thing in M&A

Mark Rayfield, CEO of Saint-Gobain North America (EPA: SGO) and CertainTeed

Integration is not just about combining processes and systems. It is about bridging cultures and creating a shared identity. However, integrating two organizations can be complex, especially when it comes to managing major cultural differences.

In this episode of the M&A Science Podcast, we explore key strategies for effectively balancing culture during an integration, featuring Mark Rayfield, CEO of Saint-Gobain North America and CertainTeed.

____________________________________________________________________________

This episode is sponsored by the M&A Science Academy, DealRoom, and FirmRoom.

To join our growing online community of M&A practitioners, visit www.mascience.com/academy.

Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at www.dealroom.net

FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com

00:00 Intro

05:50 Culture in M&A

09:59 Acquiring a competitor

11:18 Team Alignment

13:24 Understanding culture

15:45 Difficulties of Culture

16:52 Improving decision-making

18:55 Challenges for smaller companies

20:37 Lessons learned from acquisitions

24:58 Establishing strong communication

27:14 Advice on Integration

31:08 Retaining lessons learned

32:49 Ensuring deal value

34:40 Governance and M&A activities

37:20 Success metrics

38:59 Messaging with key investors

40:20 Non-core acquisitions

41:19 Cultural aspect of non-core acquisition

43:02 Craziest thing in M&A

Dr. Irit Yaniv, Founding Partner and CEO at Almeda Ventures (TLV: AMDA)

While most investors have a passive role in their portfolio company, some investors are active in shaping and contributing to its success. For venture capitalists, one of the best scenarios is for the portfolio company to be acquired to maximize investment returns.

In this episode of the M&A Science Podcast, Dr. Irit Yaniv, Founding Partner and CEO at Almada Ventures, discusses what investors can do when planning and executing the exit.

____________________________________________________________________________

This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to www.firmroom.com

00:00 Intro

03:26 M&A in the medical device industry

04:49 Minority position during Investment

05:35 When to think about an exit

06:59 Getting involved in the exit

09:57 Working with the CEO

12:03 Keeping track of potential acquisitions

14:34 Finding the right buyer

17:55 Managing exit planning disagreements

20:34 Who controls exit decisions

22:23 Negotiation

25:37 When to engage with a banker

36:51 Advice on planning an exit

38:11 Bad exits

40:29 Other takeaways

42:35 Craziest thing in M&A

Barak Routhenstein, Vice President of Corporate Development at Profile Products

The collaboration between a Private Equity (PE) firm and a portfolio company during an acquisition is a powerful partnership. Together, they create a synergistic environment where growth and value thrive.

In this episode of the M&A Science Podcast, we will explore insights from Barak Routhenstein, Vice President Corporate Development at Profile Products, on how PE firms can provide invaluable support to portfolio companies during the acquisition process, setting the stage for success and maximizing value creation.

____________________________________________________________________________

Join us on October 5th, 2023, in New York City for the M&A Science Fair 2023. Dive into a transformative M&A experience that not only emphasizes participant-driven topics but also offers an unparalleled opportunity to network with the industry's top minds.

You can elevate your M&A practice with actionable insights and top-tier networking. The event is invitation-only to ensure a curated experience. Secure your invite today!

00:00 Intro

03:57 Changes in the M&A landscape

04:39 Changes in private equity acquisitions

08:14 Go-to-market

10:48 Deal origination

12:19 International deals

14:25 How PE firms look at acquisitions

15:48 Bad cultural fit

18:40 Relationship with PE firms

20:20 Ideal PE-sponsor relationship

21:45 Managing deal sourcing conflicts

22:38 Approval process

24:44 Sustaining support from PE firms

27:08 Reporting structure

29:54 Advice for PE firms in supporting portfolio companies

32:54 Staging productive meetings

35:01 Keys to pitching a deal

38:46 Approaching target company relationships

41:28 Managing underperforming acquired companies

42:18 PE firms buying other PE firms

43:26 Craziest thing in M&A

Glenn Sanford, CEO eXp World Holdings, Inc. (NASDAQ: EXPI)

For high-growth companies, M&A is almost inevitable. If done right, it could speed up growth and open new opportunities for the acquiring entity. However, it's not without challenges, as it can also be destructive and destroy both companies involved.

In this episode of the M&A Science Podcast, Glenn Sanford, CEO eXp World Holdings, Inc., discusses the art of M&A, and striking the right balance between integration and autonomy.

____________________________________________________________________________

Join us on October 5th, 2023, in New York City for the M&A Science Fair 2023. Dive into a transformative M&A experience that not only emphasizes participant-driven topics but also offers an unparalleled opportunity to network with the industry's top minds.

You can elevate your M&A practice with actionable insights and top-tier networking. The event is invitation-only to ensure a curated experience. Secure your invite today!

00:00 Intro

03:51 EXP's acquisition history

05:31 Reasons behind EXP's acquisitions

10:12 Acquiring Success Magazine

14:22 Factors to consider when looking at potential targets

17:49 Understanding a company's culture

20:13 Reverse merger

24:38 Capital structure evolution

27:05 Managing relationships with the board of directors and shareholders

31:19 Managing integration

36:47 Other lessons and takeaways

39:03 Craziest thing in M&A